Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

460
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
460
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

2.3K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.3K
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

371
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
371
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

645
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
645
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

422
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
422
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

1.1K
Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-world incidence of cancer therapy-related cardiac dysfunction in a large, diverse, and contemporary cohort.

ESC heart failure·2026
Same author

Remote digital intervention targeting heart failure medical therapy: a randomized controlled trial.

Lancet regional health. Americas·2026
Same author

Clinical risk prediction models for worsening heart failure events and all-cause mortality in adults with mild-to-moderate chronic kidney disease.

ESC heart failure·2026
Same author

Clinical Characteristics, Early GDMT Initiation, and Likelihood of Heart Failure With Improved Ejection Fraction.

Journal of cardiac failure·2025
Same author

Worsening heart failure events in adults with mild-to-moderate chronic kidney disease.

American heart journal·2025
Same author

Enhancing risk stratification for incident systolic heart failure through machine learning and natural language processing.

American heart journal·2025

Related Experiment Video

Updated: Mar 26, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.8K

Anticoagulation management in mechanical circulatory support.

Sirtaz Adatya1, Mosi K Bennett1

  • 11 Department of Medicine, Cardiology Division, University of Chicago, Chicago, Illinois, USA ; 2 Department of Medicine, Minneapolis Heart Institute at Abbott Northwestern, Minneapolis, MN, USA.

Journal of Thoracic Disease
|January 22, 2016
PubMed
Summary
This summary is machine-generated.

Heart failure affects millions globally. Continuous flow assist devices offer advanced therapy but face complications like bleeding and thrombosis, requiring improved hemocompatibility.

Keywords:
Anticoagulationacquired von Willebrand syndromeanti-factor Xa (anti-FXa)continuous-flow left ventricular assist device (CF-LVAD)device thrombosismean arterial pressuremechanical circulatory support

More Related Videos

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

2.5K
In Vitro Thrombosis Test for Ventricular Assist Devices
09:15

In Vitro Thrombosis Test for Ventricular Assist Devices

Published on: March 21, 2025

1.4K

Related Experiment Videos

Last Updated: Mar 26, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.8K
Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

2.5K
In Vitro Thrombosis Test for Ventricular Assist Devices
09:15

In Vitro Thrombosis Test for Ventricular Assist Devices

Published on: March 21, 2025

1.4K

Area of Science:

  • Cardiology and Biomedical Engineering

Background:

  • Heart failure is a global epidemic affecting over 23 million people.
  • Advanced heart replacement therapy is often necessary due to the progressive nature of the disease.
  • Continuous flow assist devices are standard for cardiac transplantation and destination therapy (DT).

Purpose of the Study:

  • To address device-related complications hindering advancements in heart assist technology.
  • To explore strategies for improving hemocompatibility and blood flow in continuous flow assist devices.

Main Methods:

  • Focus on improving pump hemocompatibility.
  • Maximizing blood flow while minimizing adverse hemodynamic conditions.

Main Results:

  • Efforts are directed towards reducing bleeding and thrombosis.
  • Improving blood flow dynamics to prevent hemolysis, stasis, and turbulence.

Conclusions:

  • Reducing device-related complications is crucial for advancing heart assist technology.
  • Optimizing hemocompatibility and blood flow are key areas for future development.